Top 10 Social Network Startup Investors in Switzerland in November 2024

Last updated: Nov 2024 A list of 10 angel investors and VC (Venture Capital) funds that invest in Social network startups based in Switzerland. We rank investors based on the number of investments they made in Social network companies from Switzerland. We update this investor list every month.

Top 10 Social Network Startup Investors in Switzerland in November 2024

Investor	Social Network Switzerland investments
Verve Ventures	3
Sam Lim	2
SICTIC	2
Swiss Founders Fund	2
FortyOne Group	1
Zürcher Kantonal Bank	1
Foundation for Technological Innovation (FIT)	1
Randstad Innovation Fund	1
Yttrium	1
Sedo	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Zürcher Kantonalbank - as an independent, incorporated public-law institution - is wholly owned by the canton of Zurich.

Investment focus

Health Care, Medical Device, Biotechnology
Seed, Series A, Funding Round
Switzerland, Japan, Spain

Portfolio highlights

Somagenetix — Somagenetix is a new firm that wants to be a leader in gene therapy by developing first-in-class treatments for phagocyte-related illnesses. Somagenetix's mission is to use genetically modified phagocytes to treat patients suffering from immunodeficiency, neurodegeneration, and cancer with brain metastases.
Drone Harmony AG — Drone Harmony was founded in 2016 by a team of problem solvers with a passion for drones, software and automation. From their very early days, they have set out to tackle the mathematical and engineering challenges of enabling cost-effective deployment of drone technology in industries, where existing technologies were unable to deliver.DroneHarmony reinvents the way people fly drones commercially. Its 3D flight planning software turns anyone with a drone into an inspection professional. Sophisticated algorithms reduce complex industrial inspection tasks to automated and scalable workflows.
Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.

Sedo is a domain name and website marketplace and domain parking provider based in Cambridge, Massachusetts and Cologne, Germany. Sedo headquartered in Cologne and Boston (USA), is domain trading platform with 2 million customers and 19 million domains listed for sale. Sedo offers buyers and sellers a full suite of domain-related services, such asdomain parking, appraisals, transfers as well as marketing and promotional activities. For more information, please get in touch.